| Gene Symbol | TAU |
| Chromosome | 17q21.31 |
| Protein Family | MAPT family |
| Function | is an important component in the neurobiology of neurodegenerative diseases. |
| Primary Expression | neurons, where they bind to microtubules and promote their polymerization and stability |
| Subcellular Localization | Axons, Neurons |
| Molecular Weight | 45-65 kDa (isoform dependent) |
| Amino Acids | 441 aa |
| Pathways | Extracellular Aggregation, Hyperphosphorylation, Neurofibrillary Tangle Formation, Protein Assembly, Synapse Pathology |
| GeneCards | TAU |
| Human Protein Atlas | TAU |
| First characterized | 2012 |
| Primary use | Research use; emerging marker with limited clinical data |
| Source | CSF, plasma |
| Specificity | Distinguishes AD from frontotemporal dementia, Lewy body dementia, and vascular dementia with ~85% accuracy[@hansson2022] |
| Associated Diseases | ALZHEIMER, alzheimers_disease, Alzheimer's disease, apoptosis, frontotemporal_dementia, hippocampal atrophy |
| Known Drugs/Compounds | EGCG, rutin, Urolithin A |
| Interactions | Amyloid-β, APOE4, ASK1, Aβ, CDK5, GSK-3β |
| SciDEX Hypotheses | TREM2 should remain under review until replicated LRP1 should remain under review until replicated GFAP should remain under review until replicated (+2 more) |
| KG Connections | 132 knowledge graph edges |
| Databases | GeneCardsUniProtNCBI GeneHPASTRING |
No AI portrait yet
No comments yet. Be the first to comment!